Business Daily.
.
The Times Real Estate
A+ R A-
Title Filter 
Display # 
# Article Title Author Hits
1201 Hyalgan Injections are Now Being Offered by Total Health Australian Business 345
1202 KLOX Technologies gibt Genehmigung seiner innovativen Behandlung gegen Acne vulgaris in Kanada bekannt Australian Business 300
1203 Symposium visant à mettre en avant l'utilisation pratique d'un nouveau dosage des biomarqueurs dans le diagnostic de l'insuffisance rénale aiguë Australian Business 259
1204 Simposio destinado a resaltar la aplicación práctica de nuevos biomarcadores para el daño renal agudo Australian Business 350
1205 Amgen And AstraZeneca Highlight Data To Be Presented At 22nd Congress Of The European Academy Of Dermatology And Venereology Australian Business 334
1206 Simposio per evidenziare l'utilizzo pratico del nuovo test dei biomarcatori per grave insufficienza renale Australian Business 328
1207 IMMUNE Pharmaceuticals Inc. to Present at 12th Annual BIO Investor Forum Australian Business 308
1208 New England Biolabs Intends to Appeal Court Decision in Lawsuit over Theft of its Trade Secrets Australian Business 235
1209 Nektar to Host Investor and Analyst R D Day in New York City Australian Business 288
1210 Weight Loss Surgery from Beverly Hills Physicians can Change Lives Australian Business 265
1211 Severely Obese Benefit from Multifaceted Approach to Weight Loss, Says Dr. Feiz Australian Business 310
1212 Stop Unnecessary Suffering by Detecting Common Indoor Allergens with PRO-LAB's® NEW Allergen Test Kit Australian Business 395
1213 Inova to Bring Healthplex to Akridge and Soave Enterprises' Loudoun Parkway Center Australian Business 296
1214 La Comisión Europea aprueba la ampliación en la indicación de Zonegran® (zonisamida) para su uso en niños con epilepsia parcial Australian Business 409
1215 La Commissione Europea approva l'indicazione per l'uso di Zonegran® (zonisamide) nei bambini con epilessia parziale Australian Business 328
1216 Eisai's Zonegran® (zonisamide) geregistreerd voor gebruik bij kinderen met partiële epilepsie in het VK en Nederland Australian Business 310
1217 Eisais Zonegran® (Zonisamid) für Kinder mit fokalen Anfällen in Deutschland und Österreich zugelassen Australian Business 376
1218 Eisais Zonisamid für Kinder mit fokalen Anfällen in Deutschland und Österreich zugelassen Australian Business 406
1219 La Commission Européenne donne son feu vert a l'extension des indications de Zonegran® (zonisamide) chez les enfants atteints de crises d'épilepsie partielles Australian Business 358
1220 ScriptPro Certified with Appriss NPLEx Australian Business 254

Page 61 of 96

Business Daily Media